Transcranial Direct Current Stimulation (tDCS) Improves Functional Outcomes in Acute Stroke Patients
Launched by UNIVERSITY OF LIEGE · Mar 22, 2019
Trial Information
Current as of May 08, 2025
Unknown status
Keywords
ClinConnect Summary
Recruitment :
Patients with acute stroke (24-48h after stroke) who have upper and / or lower sensorimotor deficits
• Treatment : After being selected according to the inclusion and exclusion criteria of this study, patients will be randomized and placed in one of two groups: placebo (P) or transcranial anodic stimulation (A).
Once placed in one of two groups, patients will all receive intensive physiotherapy for functional improvement in order to increase motor, postural and motor control. This physiotherapy will be established 5 times a week (Monday to Friday).
In addition to physiothe...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Woman or man
- • Between 18 and 80 years old
- • First ever stroke
- • Capable of signing the consent form
- Exclusion Criteria:
- • One on the TSST (in high and relatively high risk sections)
- • Previous neurological or orthopedic pathologies affecting limbs
- • Cognitive deficits
About University Of Liege
The University of Liège, a prestigious research institution in Belgium, is committed to advancing medical science through innovative clinical trials. With a focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and biomedical engineering, to conduct high-quality research aimed at improving patient outcomes. The institution fosters a rigorous ethical framework and adheres to international standards in clinical research, ensuring the integrity and reliability of its studies. Through its clinical trials, the University of Liège aims to contribute significantly to the development of novel therapeutic approaches and enhance the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Liege, , Belgium
Patients applied
Trial Officials
Stephen Bornheim, Msc
Principal Investigator
Liege Univeristy Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials